Answers are grounded in this paper and cite their sources.
Cross-sectional study reports hyperthyroidism in 8.5% of patients with atrial fibrillation, indicating gender and comorbidity associations.
Background: Hyperthyroidism is a recognized secondary cause of atrial fibrillation (AF) and contributes to increased morbidity. Early identification is essential for timely management. Objective: To determine the frequency of hyperthyroidism in patients presenting with atrial fibrillation and its associated factors. Study Design: Cross-sectional study. Setting: Department of Cardiology, Khyber Teaching Hospital, Peshawar, Pakistan. Duration of Study: From 07-February-2025 to 07-June-2025. Methods: A total of 260 patients with ECG-confirmed AF were enrolled. Diagnosis of hyperthyroidism was based on clinical features (weight loss, palpitations, tremors) and laboratory analysis (serum TSH <0.5 mIU/L with either free T3 >450 pg/dL or free T4 >1.8 ng/dL). Data on demographics, BMI, and comorbidities were collected. Statistical analysis was performed using SPSS; p-values <0.05 were considered significant. Results: The mean age was 51.05 ± 12.38 years, with 135 males (51.9%) and 125 females (48.1%). Hyperthyroidism was identified in 22 patients (8.5%). Female gender (p = 0.04) and presence of comorbidities (p = 0.003) were significantly associated with hyperthyroidism, while age and BMI showed no significant association. Conclusion: Hyperthyroidism was present in 8.5% of patients with AF, showing a significant association with female gender and comorbid conditions. Routine thyroid function screening is recommended in AF patients, particularly in females and those with comorbidities.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: